1-3 of 3
Berdien Oortgiesen
Close
Sort by
Journal Articles

No Decrease in Fracture Risk Despite 15 Years of Treatment Evolution in Multiple Myeloma Patients: A Danish Nationwide Case-Control Study

Berdien Oortgiesen, Annemariek Driessen, Mels Hoogendoorn, Dr., Robby Kibbelaar, Dr., Nic Veeger, Dr., Joop van der Bergh, Peter Vestergaard, Frank de Vries, Eric van Roon, Prof. Dr.
Journal: Blood
Blood (2019) 134 (Supplement_1): 5503.
https://doi.org/10.1182/blood-2019-122563
Published: 2019
Journal Articles

Peripheral Neuropathy and Hypovitaminosis D Are Associated in Multiple Myeloma Patients

Berdien Oortgiesen, Hans Kroes, Petra Scholtens, Jitske Hoogland, Pauline Dannenberg-de Keijzer, Claire Siemes, MD PhD, Frank Jansman, Robby Kibbelaar, Dr., Nic Veeger, Dr., Mels Hoogendoorn, Dr., Eric van Roon, Prof. Dr.
Journal: Blood
Blood (2019) 134 (Supplement_1): 5506.
https://doi.org/10.1182/blood-2019-130611
Published: 2019
Journal Articles

Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study

Berdien Oortgiesen, Eric N. van Roon, PharmD, PhD, Peter Joosten, MD, Robby Kibbelaar, MD PhD, Huib Storm, PhD, Sjoerd Hovenga, MDPhD, Bas P Van Rees, MD PhD, Gerhard Woolthuis, MD, Nic J.G.M. Veeger, PhD, Mels Hoogendoorn, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2136.
https://doi.org/10.1182/blood.V124.21.2136.2136
Published: 2014